title: The pharmacodynamic and pharmacokinetic interaction between single doses of flecainide acetate and verapamil: effects on cardiac function and drug clearance.
abstract: Flecainide and verapamil are antiarrhythmic agents that may be used in combination. We have examined their pharmacodynamic interaction by M-mode echocardiography and electrocardiography in eight normal male volunteers (24 +/- 1.8 years of age). Flecainide decreased the left ventricular ejection fraction (LVEF) (-4.4 +/- 1.2%, p less than 0.008), but verapamil did not. Neither drug affected cardiac output or vascular resistance. Both drugs increased the PR interval (12 +/- 4 msec, p less than 0.01 for flecainide; 12 +/- 5, p less than 0.04 for verapamil). Flecainide, but not verapamil, increased the QTc interval (23 +/- 8 msec, p less than 0.02). Both drugs also increased the systolic time interval ratio (PEPc/LVETc) (0.074 +/- 0.012, p less than 0.0004 for flecainide; 0.029 +/- 0.008, p less than 0.007 for verapamil). The combination of flecainide and verapamil had additive effects on myocardial contractility and on atrioventricular conduction. Verapamil slightly decreased the plasma clearance of flecainide (7.78 +/- 0.60 ml/kg/min for flecainide alone, 7.34 +/- 0.48 ml/kg/min for flecainide and verapamil together, p less than 0.05). On the other hand, flecainide had no effect on the plasma clearance of verapamil, which suggests that there was little interaction between the two drugs on their pharmacokinetic parameters.
authors.affiliation: Medical Service, Veterans Administration Medical Center, Minneapolis, MN 55417.
authors.forename: J L
authors.initials: JL
authors.lastname: Holtzman
authors.forename: D
authors.initials: D
authors.lastname: Finley
authors.forename: L
authors.initials: L
authors.lastname: Mottonen
authors.forename: D A
authors.initials: DA
authors.lastname: Berry
authors.forename: B P
authors.initials: BP
authors.lastname: Ekholm
authors.forename: D C
authors.initials: DC
authors.lastname: Kvam
authors.forename: R L
authors.initials: RL
authors.lastname: McQuinn
authors.forename: A M
authors.initials: AM
authors.lastname: Miller
mesh_terms: D000284:Administration, Oral; D000328:Adult; D004347:Drug Interactions; D004452:Echocardiography; D004562:Electrocardiography; D005424:Flecainide / Q000097:blood / Q000493:pharmacokinetics / Q000494:pharmacology*; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D008297:Male; D008657:Metabolic Clearance Rate / Q000187:drug effects; D014700:Verapamil / Q000097:blood / Q000493:pharmacokinetics / Q000494:pharmacology*
chemical_list: D014700:Verapamil; D005424:Flecainide